| Mikhail Glasionov, MD | |
|
2801 Debarr Rd, Anchorage, AK 99508-2932 | |
| (907) 258-2149 | |
| (907) 258-2147 |
| Full Name | Mikhail Glasionov |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 40 Years |
| Location | 2801 Debarr Rd, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326037896 | NPI | - | NPPES |
| 8428443 | Other | WA | WA MEDICAID |
| MD0365 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 3953 (Alaska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chugach Anesthesia Llc | 2961465653 | 18 |
News Archive
Slightly over 5 percent of the nearly 39 million Americans age 65 and older in 2007 reported one or more cognitive disorders, such as senility or dementia, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
EKF Diagnostics, the global in vitro diagnostics company, announces that it has introduced one of the first tests to precisely measure levels of COVID-19 neutralizing antibodies in individuals.
Alterations in the topoisomerase II alpha (TOP2A) gene were associated with better patient outcomes following anthracycline-based therapy compared with non-anthracycline-based regimens, according to a study in the April 28 online issue of the Journal of the National Cancer Institute.
An international vaccine symposium sponsored by the University of Texas Medical Branch at Galveston and scheduled for Feb. 7-9 will reflect a dramatic shift in the world of vaccinology, according to Alan Barrett, director of UTMB's Sealy Center for Vaccine Development.
› Verified 2 days ago
| Entity Name | Denali Anesthesia, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508854712 PECOS PAC ID: 2567455678 Enrollment ID: O20040405001747 |
News Archive
Slightly over 5 percent of the nearly 39 million Americans age 65 and older in 2007 reported one or more cognitive disorders, such as senility or dementia, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
EKF Diagnostics, the global in vitro diagnostics company, announces that it has introduced one of the first tests to precisely measure levels of COVID-19 neutralizing antibodies in individuals.
Alterations in the topoisomerase II alpha (TOP2A) gene were associated with better patient outcomes following anthracycline-based therapy compared with non-anthracycline-based regimens, according to a study in the April 28 online issue of the Journal of the National Cancer Institute.
An international vaccine symposium sponsored by the University of Texas Medical Branch at Galveston and scheduled for Feb. 7-9 will reflect a dramatic shift in the world of vaccinology, according to Alan Barrett, director of UTMB's Sealy Center for Vaccine Development.
› Verified 2 days ago
| Entity Name | Chugach Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093712358 PECOS PAC ID: 2961465653 Enrollment ID: O20041109001035 |
News Archive
Slightly over 5 percent of the nearly 39 million Americans age 65 and older in 2007 reported one or more cognitive disorders, such as senility or dementia, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
EKF Diagnostics, the global in vitro diagnostics company, announces that it has introduced one of the first tests to precisely measure levels of COVID-19 neutralizing antibodies in individuals.
Alterations in the topoisomerase II alpha (TOP2A) gene were associated with better patient outcomes following anthracycline-based therapy compared with non-anthracycline-based regimens, according to a study in the April 28 online issue of the Journal of the National Cancer Institute.
An international vaccine symposium sponsored by the University of Texas Medical Branch at Galveston and scheduled for Feb. 7-9 will reflect a dramatic shift in the world of vaccinology, according to Alan Barrett, director of UTMB's Sealy Center for Vaccine Development.
› Verified 2 days ago
| Entity Name | New Frontier Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255604948 PECOS PAC ID: 2567624257 Enrollment ID: O20120425000361 |
News Archive
Slightly over 5 percent of the nearly 39 million Americans age 65 and older in 2007 reported one or more cognitive disorders, such as senility or dementia, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
EKF Diagnostics, the global in vitro diagnostics company, announces that it has introduced one of the first tests to precisely measure levels of COVID-19 neutralizing antibodies in individuals.
Alterations in the topoisomerase II alpha (TOP2A) gene were associated with better patient outcomes following anthracycline-based therapy compared with non-anthracycline-based regimens, according to a study in the April 28 online issue of the Journal of the National Cancer Institute.
An international vaccine symposium sponsored by the University of Texas Medical Branch at Galveston and scheduled for Feb. 7-9 will reflect a dramatic shift in the world of vaccinology, according to Alan Barrett, director of UTMB's Sealy Center for Vaccine Development.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mikhail Glasionov, MD Po Box 202149, Anchorage, AK 99520-2149 Ph: (907) 258-2149 | Mikhail Glasionov, MD 2801 Debarr Rd, Anchorage, AK 99508-2932 Ph: (907) 258-2149 |
News Archive
Slightly over 5 percent of the nearly 39 million Americans age 65 and older in 2007 reported one or more cognitive disorders, such as senility or dementia, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
EKF Diagnostics, the global in vitro diagnostics company, announces that it has introduced one of the first tests to precisely measure levels of COVID-19 neutralizing antibodies in individuals.
Alterations in the topoisomerase II alpha (TOP2A) gene were associated with better patient outcomes following anthracycline-based therapy compared with non-anthracycline-based regimens, according to a study in the April 28 online issue of the Journal of the National Cancer Institute.
An international vaccine symposium sponsored by the University of Texas Medical Branch at Galveston and scheduled for Feb. 7-9 will reflect a dramatic shift in the world of vaccinology, according to Alan Barrett, director of UTMB's Sealy Center for Vaccine Development.
› Verified 2 days ago
Colby Parks, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: Providence Anchorage Anesthesia Medical Group, P.c., Suite 207, Anchorage, AK 99508 Phone: 907-561-0005 Fax: 907-563-9140 | |
Thomas Weissmueller, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3300 Providence Dr Ste 205, Anchorage, AK 99508 Phone: 907-561-1510 | |
Robert C Gudor, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2801 Debarr Rd, Anchorage, AK 99508 Phone: 907-258-2149 Fax: 907-258-2147 | |
Richard F Farah, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3300 Providence Dr, Suite 207, Providence Anchorage Anesthesia Medical Grou, Anchorage, AK 99508 Phone: 907-561-0005 Fax: 907-563-9140 | |
Katharine Lamperti, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 3300 Providence Dr., Suite 207, Providence Anchorage Anesthesia Medical Group, P.c., Anchorage, AK 99508 Phone: 907-561-0005 Fax: 907-563-9140 | |
Harold W Schneider, Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-563-2662 | |
Mary R Lanza, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 3300 Providence Dr Ste 207, Providence Anchorage Anesthesia Medical Group, P.c., Anchorage, AK 99508 Phone: 907-561-0005 Fax: 907-563-9140 |